Abiopharma

Mahony Susan 🟢 acquired 19.2K shares (2 derivative) of Zymeworks Inc. (ZYME) at $23.16 Transaction Date: Jan 12, 2026 | Filing ID: 010843

Moore Paul Andrew 🟡 adjusted position in 173.4K shares (4 derivative) of Zymeworks Inc. (ZYME) at $23.16 ($1.8M) Transaction Date: Jan 12, 2026 | Filing ID: 010834

Director Wells David R. 🟢 acquired 15.0K shares (1 derivative) of HeartSciences Inc. (HSCS) Transaction Date: Jan 12, 2026 | Filing ID: 003616

Director Bent Bruce 🟢 acquired 15.0K shares (1 derivative) of HeartSciences Inc. (HSCS) Transaction Date: Jan 12, 2026 | Filing ID: 003615

New Form SCHEDULE 13G/A - CVRx, Inc. Filed: 2026-01-12 AccNo: 0000904454-26-000015 Size: 9 KB

📋 Heery Christopher (Officer) plans to sell 6K shares of Arcellx, Inc. (at $64.15 each, total $393K) Filed: Jan 12, 2026 | ID: 000003

New Form 3 - ENvue Medical, Inc. Filed: 2026-01-12 AccNo: 0001493152-26-001911 Size: 3 KB

Director Laumas Sandeep 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002981

Director Patni Rajiv 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002980

Galbraith Kenneth 🟡 adjusted position in 551.6K shares (4 derivative) of Zymeworks Inc. (ZYME) at $23.16 ($5.7M) Transaction Date: Jan 12, 2026 | Filing ID: 010790